MyFinsight
Home
Blog
About
Back
Cash Flow
Cyclerion Therapeutics, Inc. (CYCN)
Cyclerion Therapeutics, Inc. (CYCN)
source: myfinsight.com
Net decrease in cash
and cash...
-$1,432K
(-533.63%↓ Y/Y)
Accounts payable
$1,140K
(1483.33%↑ Y/Y)
Prepaid expenses
-$143K
(-448.78%↓ Y/Y)
Share-based compensation
expense
$51K
(-77.63%↓ Y/Y)
Net cash used in
operating activities
-$1,432K
(2.65%↑ Y/Y)
Canceled cashflow
$1,334K
Net loss
-$1,755K
(-0.11%↓ Y/Y)
Accrued expenses and
other current...
-$889K
(-5129.41%↓ Y/Y)
Accrued research and
development costs
-$122K
(-710.00%↓ Y/Y)
Back